microRNA information: hsa-miR-199b-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-199b-3p | miRbase |
Accession: | MIMAT0004563 | miRbase |
Precursor name: | hsa-mir-199b | miRbase |
Precursor accession: | MI0000282 | miRbase |
Symbol: | MIR199B | HGNC |
RefSeq ID: | NR_029619 | GenBank |
Sequence: | ACAGUAGUCUGCACAUUGGUUA |
Reported expression in cancers: hsa-miR-199b-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-199b-3p | acute myeloid leukemia | downregulation | "miR 199b a novel tumor suppressor miRNA in acute m ......" | 26848406 | |
hsa-miR-199b-3p | bladder cancer | deregulation | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | qPCR |
hsa-miR-199b-3p | colorectal cancer | deregulation | "In the present study by comparing the miRNA expres ......" | 27145368 | |
hsa-miR-199b-3p | colorectal cancer | deregulation | "Downregulation of microRNA 199b predicts unfavorab ......" | 27517624 | |
hsa-miR-199b-3p | liver cancer | deregulation | "Underexpressed microRNA 199b 5p targets hypoxia in ......" | 21557766 | |
hsa-miR-199b-3p | thyroid cancer | deregulation | "A miR-microarray study was conducted to identify m ......" | 24631480 | Microarray; qPCR |
hsa-miR-199b-3p | thyroid cancer | deregulation | "Serum miRNA was quantified in 31 female thyroidect ......" | 26341226 | qPCR |
Reported cancer pathway affected by hsa-miR-199b-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-199b-3p | acute myeloid leukemia | Apoptosis pathway | "miR 199b a novel tumor suppressor miRNA in acute m ......" | 26848406 | |
hsa-miR-199b-3p | sarcoma | Notch signaling pathway | "MicroRNA 199b 5p is involved in the Notch signalin ......" | 23574781 | |
hsa-miR-199b-3p | thyroid cancer | cell cycle pathway; Apoptosis pathway | "A miR-microarray study was conducted to identify m ......" | 24631480 |
Reported cancer prognosis affected by hsa-miR-199b-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-199b-3p | acute myeloid leukemia | poor survival | "miR 199b a novel tumor suppressor miRNA in acute m ......" | 26848406 | |
hsa-miR-199b-3p | bladder cancer | staging | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | |
hsa-miR-199b-3p | colorectal cancer | metastasis; staging; poor survival; worse prognosis | "Downregulation of miR 199b is associated with dist ......" | 27145368 | Luciferase |
hsa-miR-199b-3p | colorectal cancer | worse prognosis; metastasis; progression; poor survival | "Downregulation of microRNA 199b predicts unfavorab ......" | 27517624 | |
hsa-miR-199b-3p | liver cancer | worse prognosis; progression; poor survival; malignant trasformation | "Underexpressed microRNA 199b 5p targets hypoxia in ......" | 21557766 | Western blot; Luciferase |
hsa-miR-199b-3p | ovarian cancer | drug resistance | "Epigenetic silencing of microRNA 199b 5p is associ ......" | 24659709 |
Reported gene related to hsa-miR-199b-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-199b-3p | breast cancer | ERBB2 | "MiR 199b 5p targets HER2 in breast cancer cells ......" | 23296799 |
hsa-miR-199b-3p | acute myeloid leukemia | HDAC9 | "Treatment of THP-1 cells represents M5-subtype wit ......" | 26848406 |
hsa-miR-199b-3p | acute myeloid leukemia | HOXA7 | "Furthermore significant inverse correlation of Hox ......" | 26848406 |
hsa-miR-199b-3p | acute myeloid leukemia | HOXB6 | "Furthermore significant inverse correlation of Hox ......" | 26848406 |
hsa-miR-199b-3p | colorectal cancer | KRAS | "The miR-199b prognostic impact was particularly ev ......" | 27517624 |
hsa-miR-199b-3p | ovarian cancer | NOTCH1 | "Epigenetic silencing of microRNA 199b 5p is associ ......" | 24659709 |
hsa-miR-199b-3p | acute myeloid leukemia | PODXL | "Previously we demonstrated that miR-199b was signi ......" | 26848406 |
hsa-miR-199b-3p | colorectal cancer | SIRT1 | "Downregulation of miR 199b is associated with dist ......" | 27145368 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-199b-3p | YWHAE | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA | MirTarget; PITA; miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.07; TCGA CESC -0.064; TCGA COAD -0.109; TCGA HNSC -0.081; TCGA KIRP -0.076; TCGA LGG -0.068; TCGA LUAD -0.091; TCGA OV -0.108; TCGA PAAD -0.199; TCGA PRAD -0.121; TCGA THCA -0.074 |
hsa-miR-199b-3p | FAM199X | 10 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.054; TCGA ESCA -0.145; TCGA HNSC -0.143; TCGA LUAD -0.065; TCGA LUSC -0.125; TCGA PRAD -0.11; TCGA SARC -0.172; TCGA THCA -0.058; TCGA STAD -0.127; TCGA UCEC -0.096 |
hsa-miR-199b-3p | PPP1R9A | 10 cancers: BLCA; ESCA; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget; PITA; miRNATAP | TCGA BLCA -0.589; TCGA ESCA -0.691; TCGA KIRP -0.109; TCGA LGG -0.113; TCGA LUAD -0.13; TCGA LUSC -0.759; TCGA PAAD -0.471; TCGA PRAD -0.139; TCGA THCA -0.062; TCGA STAD -0.362 |
hsa-miR-199b-3p | KIAA0141 | 12 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.171; TCGA BRCA -0.069; TCGA COAD -0.099; TCGA ESCA -0.205; TCGA LIHC -0.052; TCGA LUAD -0.117; TCGA LUSC -0.105; TCGA PAAD -0.092; TCGA PRAD -0.077; TCGA SARC -0.053; TCGA THCA -0.076; TCGA STAD -0.093 |
hsa-miR-199b-3p | NRBP2 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LIHC; LUSC; SARC; STAD | MirTarget | TCGA BLCA -0.097; TCGA BRCA -0.085; TCGA KIRC -0.351; TCGA KIRP -0.25; TCGA LGG -0.12; TCGA LIHC -0.128; TCGA LUSC -0.221; TCGA SARC -0.305; TCGA STAD -0.137 |
hsa-miR-199b-3p | NLK | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.093; TCGA BRCA -0.079; TCGA CESC -0.059; TCGA COAD -0.099; TCGA ESCA -0.209; TCGA LIHC -0.068; TCGA LUAD -0.063; TCGA LUSC -0.217; TCGA PAAD -0.307; TCGA SARC -0.088; TCGA THCA -0.055; TCGA UCEC -0.076 |
hsa-miR-199b-3p | CETN3 | 9 cancers: BLCA; HNSC; KIRC; LIHC; LUSC; OV; PAAD; PRAD; UCEC | MirTarget; PITA | TCGA BLCA -0.122; TCGA HNSC -0.094; TCGA KIRC -0.057; TCGA LIHC -0.082; TCGA LUSC -0.171; TCGA OV -0.125; TCGA PAAD -0.133; TCGA PRAD -0.082; TCGA UCEC -0.071 |
hsa-miR-199b-3p | FAM60A | 9 cancers: BLCA; CESC; COAD; KIRP; LGG; OV; PRAD; SARC; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.122; TCGA CESC -0.097; TCGA COAD -0.175; TCGA KIRP -0.052; TCGA LGG -0.123; TCGA OV -0.118; TCGA PRAD -0.086; TCGA SARC -0.101; TCGA UCEC -0.068 |
hsa-miR-199b-3p | KDM3A | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; SARC | MirTarget; miRNATAP | TCGA BLCA -0.128; TCGA CESC -0.073; TCGA COAD -0.143; TCGA HNSC -0.096; TCGA KIRC -0.191; TCGA KIRP -0.08; TCGA LGG -0.054; TCGA LIHC -0.077; TCGA LUSC -0.097; TCGA SARC -0.115 |
hsa-miR-199b-3p | KIAA0907 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; UCEC | MirTarget; PITA | TCGA BLCA -0.167; TCGA BRCA -0.143; TCGA KIRC -0.25; TCGA KIRP -0.096; TCGA LGG -0.051; TCGA LIHC -0.116; TCGA LUSC -0.203; TCGA OV -0.057; TCGA UCEC -0.143 |
hsa-miR-199b-3p | ZC3H14 | 10 cancers: BLCA; COAD; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.088; TCGA COAD -0.126; TCGA LUAD -0.124; TCGA LUSC -0.09; TCGA OV -0.065; TCGA PAAD -0.174; TCGA PRAD -0.098; TCGA SARC -0.106; TCGA THCA -0.066; TCGA STAD -0.102 |
hsa-miR-199b-3p | RHOT1 | 10 cancers: BLCA; CESC; COAD; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD | MirTarget; PITA | TCGA BLCA -0.076; TCGA CESC -0.07; TCGA COAD -0.086; TCGA LUAD -0.104; TCGA LUSC -0.113; TCGA OV -0.058; TCGA PAAD -0.101; TCGA SARC -0.122; TCGA THCA -0.077; TCGA STAD -0.212 |
hsa-miR-199b-3p | ARG2 | 9 cancers: BLCA; COAD; HNSC; LIHC; OV; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.223; TCGA COAD -0.132; TCGA HNSC -0.209; TCGA LIHC -0.088; TCGA OV -0.076; TCGA PAAD -0.337; TCGA SARC -0.218; TCGA THCA -0.104; TCGA STAD -0.145 |
hsa-miR-199b-3p | KIAA0319L | 10 cancers: BLCA; BRCA; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.068; TCGA BRCA -0.161; TCGA ESCA -0.244; TCGA LUAD -0.068; TCGA LUSC -0.094; TCGA PAAD -0.103; TCGA PRAD -0.153; TCGA THCA -0.081; TCGA STAD -0.086; TCGA UCEC -0.073 |
hsa-miR-199b-3p | SLC38A1 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; SARC; UCEC | PITA | TCGA BLCA -0.156; TCGA CESC -0.142; TCGA COAD -0.129; TCGA HNSC -0.111; TCGA KIRC -0.181; TCGA KIRP -0.077; TCGA LGG -0.1; TCGA SARC -0.431; TCGA UCEC -0.174 |
hsa-miR-199b-3p | ACVR2B | 13 cancers: BLCA; ESCA; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.159; TCGA ESCA -0.137; TCGA KIRP -0.078; TCGA LGG -0.22; TCGA LUAD -0.109; TCGA LUSC -0.153; TCGA OV -0.082; TCGA PAAD -0.304; TCGA PRAD -0.116; TCGA SARC -0.079; TCGA THCA -0.07; TCGA STAD -0.161; TCGA UCEC -0.06 |
hsa-miR-199b-3p | OXSR1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; STAD | PITA; miRNATAP | TCGA BLCA -0.062; TCGA CESC -0.104; TCGA COAD -0.079; TCGA ESCA -0.174; TCGA HNSC -0.061; TCGA LUAD -0.061; TCGA LUSC -0.062; TCGA SARC -0.092; TCGA STAD -0.129 |
hsa-miR-199b-3p | TACC2 | 10 cancers: BLCA; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | PITA; miRNATAP | TCGA BLCA -0.148; TCGA ESCA -0.256; TCGA LGG -0.064; TCGA LIHC -0.07; TCGA LUAD -0.366; TCGA LUSC -0.155; TCGA PAAD -0.293; TCGA SARC -0.431; TCGA THCA -0.072; TCGA STAD -0.206 |
hsa-miR-199b-3p | UBL3 | 9 cancers: BLCA; COAD; ESCA; LGG; LUAD; PAAD; PRAD; THCA; STAD | PITA | TCGA BLCA -0.081; TCGA COAD -0.129; TCGA ESCA -0.386; TCGA LGG -0.073; TCGA LUAD -0.173; TCGA PAAD -0.168; TCGA PRAD -0.094; TCGA THCA -0.052; TCGA STAD -0.298 |
hsa-miR-199b-3p | MKRN1 | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.095; TCGA BRCA -0.071; TCGA ESCA -0.126; TCGA HNSC -0.093; TCGA KIRP -0.058; TCGA LGG -0.052; TCGA LUAD -0.056; TCGA LUSC -0.144; TCGA PAAD -0.136; TCGA PRAD -0.057; TCGA SARC -0.094; TCGA STAD -0.066; TCGA UCEC -0.053 |
hsa-miR-199b-3p | PLEKHH1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA | PITA; miRNATAP | TCGA BLCA -0.388; TCGA BRCA -0.1; TCGA CESC -0.178; TCGA ESCA -0.889; TCGA HNSC -0.3; TCGA KIRC -0.135; TCGA KIRP -0.212; TCGA LIHC -0.111; TCGA LUSC -0.316; TCGA PAAD -0.351; TCGA PRAD -0.249; TCGA THCA -0.062 |
hsa-miR-199b-3p | ANKRD52 | 9 cancers: BLCA; CESC; ESCA; KIRP; LIHC; LUAD; PAAD; PRAD; SARC | PITA; miRNATAP | TCGA BLCA -0.07; TCGA CESC -0.104; TCGA ESCA -0.121; TCGA KIRP -0.06; TCGA LIHC -0.109; TCGA LUAD -0.065; TCGA PAAD -0.14; TCGA PRAD -0.084; TCGA SARC -0.064 |
hsa-miR-199b-3p | SLC45A4 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.103; TCGA BRCA -0.093; TCGA ESCA -0.355; TCGA HNSC -0.122; TCGA LUAD -0.132; TCGA PAAD -0.152; TCGA PRAD -0.057; TCGA THCA -0.096; TCGA UCEC -0.127 |
hsa-miR-199b-3p | LYRM2 | 10 cancers: BLCA; COAD; ESCA; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.089; TCGA COAD -0.084; TCGA ESCA -0.099; TCGA LUAD -0.087; TCGA OV -0.137; TCGA PAAD -0.164; TCGA PRAD -0.128; TCGA SARC -0.056; TCGA STAD -0.137; TCGA UCEC -0.053 |
hsa-miR-199b-3p | MLLT6 | 9 cancers: BLCA; BRCA; ESCA; LGG; LIHC; LUSC; PAAD; PRAD; SARC | mirMAP; miRNATAP | TCGA BLCA -0.149; TCGA BRCA -0.108; TCGA ESCA -0.231; TCGA LGG -0.082; TCGA LIHC -0.066; TCGA LUSC -0.171; TCGA PAAD -0.138; TCGA PRAD -0.074; TCGA SARC -0.123 |
hsa-miR-199b-3p | PGPEP1 | 9 cancers: BLCA; BRCA; ESCA; LIHC; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.24; TCGA BRCA -0.153; TCGA ESCA -0.614; TCGA LIHC -0.117; TCGA LUSC -0.127; TCGA PAAD -0.232; TCGA PRAD -0.059; TCGA SARC -0.212; TCGA THCA -0.113 |
hsa-miR-199b-3p | MBD1 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.131; TCGA BRCA -0.08; TCGA CESC -0.06; TCGA HNSC -0.073; TCGA KIRC -0.066; TCGA LUSC -0.064; TCGA PAAD -0.121; TCGA SARC -0.067; TCGA STAD -0.076 |
hsa-miR-199b-3p | LIMD1 | 11 cancers: BLCA; CESC; ESCA; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.183; TCGA CESC -0.094; TCGA ESCA -0.304; TCGA KIRP -0.064; TCGA LIHC -0.076; TCGA LUAD -0.269; TCGA LUSC -0.21; TCGA PRAD -0.084; TCGA SARC -0.084; TCGA THCA -0.068; TCGA STAD -0.15 |
hsa-miR-199b-3p | RBM47 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.141; TCGA COAD -0.189; TCGA ESCA -0.691; TCGA HNSC -0.247; TCGA LUAD -0.16; TCGA LUSC -0.21; TCGA PRAD -0.114; TCGA THCA -0.064; TCGA UCEC -0.163 |
hsa-miR-199b-3p | LUC7L3 | 10 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.058; TCGA KIRC -0.175; TCGA KIRP -0.137; TCGA LGG -0.13; TCGA LIHC -0.065; TCGA LUSC -0.227; TCGA PAAD -0.104; TCGA SARC -0.055; TCGA UCEC -0.074 |
hsa-miR-199b-3p | SCAI | 12 cancers: BLCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.092; TCGA COAD -0.091; TCGA HNSC -0.091; TCGA LGG -0.055; TCGA LIHC -0.06; TCGA LUAD -0.185; TCGA LUSC -0.207; TCGA OV -0.071; TCGA PAAD -0.157; TCGA PRAD -0.103; TCGA SARC -0.105; TCGA STAD -0.134 |
hsa-miR-199b-3p | MFSD6 | 12 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.144; TCGA COAD -0.141; TCGA ESCA -0.151; TCGA HNSC -0.092; TCGA LGG -0.052; TCGA LUAD -0.087; TCGA LUSC -0.106; TCGA PAAD -0.198; TCGA PRAD -0.1; TCGA SARC -0.327; TCGA THCA -0.087; TCGA STAD -0.184 |
hsa-miR-199b-3p | ITPK1 | 9 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; SARC; THCA | MirTarget; PITA; miRNATAP | TCGA BRCA -0.209; TCGA ESCA -0.379; TCGA HNSC -0.061; TCGA LGG -0.08; TCGA LUAD -0.133; TCGA LUSC -0.128; TCGA PAAD -0.133; TCGA SARC -0.343; TCGA THCA -0.059 |
hsa-miR-199b-3p | CCDC85C | 11 cancers: BRCA; CESC; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.163; TCGA CESC -0.15; TCGA HNSC -0.183; TCGA LGG -0.08; TCGA LIHC -0.114; TCGA LUAD -0.119; TCGA PAAD -0.257; TCGA PRAD -0.192; TCGA SARC -0.197; TCGA THCA -0.115; TCGA STAD -0.186 |
hsa-miR-199b-3p | LLGL2 | 9 cancers: BRCA; ESCA; HNSC; LIHC; LUSC; PAAD; SARC; THCA; UCEC | PITA; miRNATAP | TCGA BRCA -0.274; TCGA ESCA -0.707; TCGA HNSC -0.286; TCGA LIHC -0.07; TCGA LUSC -0.264; TCGA PAAD -0.473; TCGA SARC -0.19; TCGA THCA -0.077; TCGA UCEC -0.099 |
hsa-miR-199b-3p | MMAB | 11 cancers: BRCA; HNSC; LGG; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | PITA | TCGA BRCA -0.107; TCGA HNSC -0.147; TCGA LGG -0.087; TCGA LIHC -0.117; TCGA LUAD -0.121; TCGA OV -0.082; TCGA PAAD -0.402; TCGA PRAD -0.091; TCGA THCA -0.077; TCGA STAD -0.147; TCGA UCEC -0.072 |
hsa-miR-199b-3p | IMMT | 10 cancers: CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | PITA | TCGA CESC -0.071; TCGA COAD -0.075; TCGA ESCA -0.086; TCGA HNSC -0.059; TCGA LUAD -0.072; TCGA PAAD -0.064; TCGA PRAD -0.067; TCGA SARC -0.089; TCGA STAD -0.074; TCGA UCEC -0.066 |
hsa-miR-199b-3p | SUZ12 | 10 cancers: COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | PITA; miRNATAP | TCGA COAD -0.155; TCGA ESCA -0.11; TCGA HNSC -0.106; TCGA LIHC -0.066; TCGA LUAD -0.054; TCGA LUSC -0.087; TCGA PRAD -0.094; TCGA SARC -0.154; TCGA STAD -0.101; TCGA UCEC -0.086 |
Enriched cancer pathways of putative targets